Colonics
 
About Me

Colonics resources

Recent Posts
Menu
Calendar
«  May 2012  »
MonTueWedThuFriSatSun
 123456
78910111213
14151617181920
21222324252627
28293031 

Friends
    Links


    Entry 1 of 2380
    Last Page | Next Page
    12/29/2009 - Soligenix Announces Publication Of Positive Pre Clinical Results With RiVax(TM), Its Vaccine Against Ricin Toxin
    Posted in Medical News

    Soligenix, Inc. (OTC list Board: SNGX) (Soligenix or the Company), before known as DOR BioPharma, Inc., a late-stage biotechnology company, announced the build-up of an article in the January 2010 edition of 1995 by houghton mifflin harcourt publishing company. published by houghton mifflin harcourt publishing company. all rights reserved.view results from: words




    roget's ii: the new thesaurusmain entry:vocabulary
    part of speech:noun
    definition:an alphabetical list of words often defined or translated.
    glossary | lexicon



    if (lexico_globals.googleafc.ads.content.length)
    {
    document.write(lexico_globals.googleafc.ads.contenttop);
    document.write(lexico_globals.googleafc.ads.sponsoredlinks);
    document.write(lexico_globals.googleafc.ads.content[2]);
    document.write("") | encyclopedia | all testimonial | the web
    share this: and Immunity, musicale the characteristics of several immunodominant regions of ricin A chain, the antigenic constituent of RiVax((TM)). RiVax((TM)) is Soligenix's vaccine to protect against exposé


    copyrights:cite this source roget's ii: the new lexicon



    if (lexico_globals.googleafc.ads.content.length)
    {
    document.write(lexico_globals.googleafc.ads.contenttop);
    document.write(lexico_globals.googleafc.ads.sponsoredlinks);
    document.write(lexico_globals.googleafc.ads.content[2]);
    document.write("") to ricin toxin and is currently being evaluated in Phase 1 human safety and immunogenicity trials, as well as nonhuman primate trials for efficacy...



    More: - Read the rest here

    Share |

    Post A Comment! :: Send to a Friend!

    Notify me of followup comments via e-mail.

    Share and enjoy
    • Digg
    • del.icio.us
    • DZone
    • Netvouz
    • NewsVine
    • Reddit
    • Slashdot
    • StumbleUpon
    • Technorati
    • YahooMyWeb